Autres langues Nevro Corp.

Actions

NVRO

US64157F1030

Temps Différé Nyse Autres places de cotation 21:48:33 11/06/2024			Varia. 5j.	Varia. 1 janv.
9,24 ^USD	-2,84 %		0,00 %	-57,02 %

22/05	NEVRO CORP. : Citigroup de neutre à vendeur sur le dossier	ZM
14/05	Transcript : Nevro Corp. Presents at Bank of America Health Care Conference 2024, May-14-2024 09:20 AM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08	24/05
Nevro to Present at BofA Securities 2024 Healthcare Conference	09/05
Nevro Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Nevro : First Quarter 2024 Earnings Presentation	07/05
Earnings Flash (NVRO) NEVRO Reports Q1 Revenue $87M, vs. Street Est of $97.9M	07/05
Nevro: Q1 Earnings Snapshot	07/05
Nevro Reports First-Quarter 2024 Financial Results	07/05
Nevro Corp. Provides Earnings Guidance for the Second Quarter Ending June 30, 2024 and Revises Earnings Guidance for the Full Year Ending December 31, 2024	07/05
Nevro Corp. Announces Resignation of Richard B. Carter as Chief Accounting Officer and Principal Accounting Officer, Effective May 10, 2024	25/04
Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024	17/04
Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off	09/04
Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw	28/02
Nevro 2024 Sales Expected Slightly Below Estimates, RBC Says	22/02
Earnings Flash (NVRO) NEVRO Posts Q4 Revenue $116.2M, vs. Street Est of $116M	21/02
Engaged Capital Enters into Agreement with Nevro Corp	21/02
Nevro: Q4 Earnings Snapshot	21/02
Nevro Enters Into Cooperation Agreement With Engaged Capital	21/02
Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results	21/02
Nevro Corp. Appoints Kirt P. Karros to Board of Directors and Audit Committee of the Board	21/02
Nevro Corp. Provides Earnings Guidance for the First Quarter and Full Year of 2024	21/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Nevro Corp.

Actions

NVRO

US64157F1030

Autres langues

Filtres